Proqr Therapeutics B.V. (PRQR): ProQR shares plummet as eye disease trea...

Next 10 Prev Next

Send PM Follow Ignore

Followers	16
Posts	727
Boards Moderated	0
Alias Born	08/12/2022

TechandBio

Re: None

Saturday, 03/15/2025 10:46:20 AM

Saturday, March 15, 2025 10:46:20 AM

ProQR shares plummet as eye disease treatment flops ...
Fierce Biotech
https://www.fiercebiotech.com › biotech › proqr-treatm...
Feb 11, 2022 — ProQR's treatment for a congenital eye disease in children failed to improve vision and mobility, a tough pill to swallow that Wall Street ...
Missing: prqr ?| Show results with: prqr

ProQR to Cut 30% of Workforce, CSO Following ...
BioSpace
https://www.biospace.com › News › Drug Development
Apr 13, 2022 — In February, ProQR reported that Phase II/III clinical trials of sepofarsen failed to meet both primary and secondary endpoints. Sepofarsen is a ...
Missing: prqr ?| Show results with: prqr

ProQR eye drug comes up short in key study, surprising ...
BioPharma Dive
https://www.biopharmadive.com › news › proqr-lca-ey...
Feb 11, 2022 — The biotech's treatment did not improve vision in the Phase 2/3 trial, a significant setback that sent shares down by 75%.

$PRQR